Emicizumab-kxwh Subcutaneous and Larotrectinib Capsules
Determining the interaction of Emicizumab-kxwh Subcutaneous and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Larotrectinib Oral Solution
- Emicizumab-kxwh Subcutaneous-Larotrectinib Sulfate
- Emicizumab-kxwh Subcutaneous-Lartruvo
- Emicizumab-kxwh Subcutaneous-Larynex
- Emicizumab-kxwh Subcutaneous-Laryng-O-Jet
- Emicizumab-kxwh Subcutaneous-Laryngesic
- Larotrectinib Capsules-Emla
- Larotrectinib Capsules-Emla Topical
- Larotrectinib Capsules-Emo-Cort Scalp Solution Topical application
- Larotrectinib Capsules-Emo-Cort Topical application
- Larotrectinib Capsules-Emoquette
- Larotrectinib Capsules-Empagliflozin